Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
申请人:Ammenn Jochen
公开号:US20050272718A1
公开(公告)日:2005-12-08
The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
本发明涉及一种式 I 的黑色素浓缩激素拮抗剂化合物:(I);或其药学上可接受的盐、溶液剂、对映体或原药,可用于治疗、预防或改善与肥胖及相关疾病有关的症状。
Modular Synthesis of Candidate Indole-based Insulin Mimics by Claisen Rearrangement
作者:Xin Xiong、Michael C. Pirrung
DOI:10.1021/ol800058d
日期:2008.3.1
A modular synthetic route to (indolyl)kojic acid anti-diabetes agents has been developed. Sonogashira coupling of a protected iodoaniline with a propargyl kojate was used to construct an (indole)methyl kojate. Its heteroaromatic Claisen rearrangement, followed by tautomerization to return the indole and pyrone rings, was used to create the biaryl C-C bond. This route should enable collections of insulin mimic drug candidates to be prepared from a few basic building blocks.
US7229987B2
申请人:——
公开号:US7229987B2
公开(公告)日:2007-06-12
A Simple Synthesis of 2-Substituted Indoles
作者:Dhanapalan Nagarathnam
DOI:10.1055/s-1992-26213
日期:——
A simple preparation of 2-(dimethylaminomethyl)indole, indole-2-acetonitrile and 2-(2-arylvinyl)indoles from 2-methylindole is described.